MARTIN J TYLER 4
4 · DYNAVAX TECHNOLOGIES CORP · Filed Aug 27, 2010
Insider Transaction Report
Form 4
MARTIN J TYLER
VP Clinical Development & CMO
Transactions
- Award
Option (Right to Buy)
2010-08-25+517,244→ 517,244 totalExercise: $1.72Exp: 2020-08-24→ Common Stock (517,244 underlying)
Footnotes (2)
- [F1]This option grant shall vest in equal annual installments over four years from August 25,2010.
- [F2]Not applicable.